216 related articles for article (PubMed ID: 16621033)
1. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
Tayebi M; Hawke S
Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
[TBL] [Abstract][Full Text] [Related]
2. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
3. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
4. Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases.
Sakaguchi S; Ishibashi D; Matsuda H
Expert Opin Ther Pat; 2009 Jul; 19(7):907-17. PubMed ID: 19514955
[TBL] [Abstract][Full Text] [Related]
5. Cells and prions: a license to replicate.
Nuvolone M; Aguzzi A; Heikenwalder M
FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo neurotoxicity of prion protein oligomers.
Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
[TBL] [Abstract][Full Text] [Related]
7. [A process of programmed cell death as a mechanisms of neuronal death in prion diseases].
Chrétien F; Dorandeu A; Adle-Biassette H; Ereau T; Wingertsmann L; Brion F; Gray F
Clin Exp Pathol; 1999; 47(3-4):181-91. PubMed ID: 10472738
[TBL] [Abstract][Full Text] [Related]
8. A role for B lymphocytes in anti-infective prion therapies?
Tayebi M; Bate C; Hawke S; Williams A
Expert Rev Anti Infect Ther; 2007 Aug; 5(4):631-8. PubMed ID: 17678426
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in prion immunotherapy.
Heppner FL; Aguzzi A
Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
[TBL] [Abstract][Full Text] [Related]
10. Theoretical analysis of the implication of PrP in neuronal death during transmissible subacute spongiform encephalopathies: hypothesis of a PrP oligomeric channel.
Chapron Y; Peyrin JM; Crouzy S; Jaegly A; Dormont D
J Theor Biol; 2000 May; 204(1):103-11. PubMed ID: 10772851
[TBL] [Abstract][Full Text] [Related]
11. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
12. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
13. Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis.
Tayebi M; David M; Bate C; Jones D; Taylor W; Morton R; Pollard J; Hawke S
J Gen Virol; 2010 Dec; 91(Pt 12):3105-15. PubMed ID: 20797970
[TBL] [Abstract][Full Text] [Related]
14. Retinal function and morphology are altered in cattle infected with the prion disease transmissible mink encephalopathy.
Smith JD; Greenlee JJ; Hamir AN; Richt JA; Greenlee MH
Vet Pathol; 2009 Sep; 46(5):810-8. PubMed ID: 19429980
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis.
Féraudet-Tarisse C; Andréoletti O; Morel N; Simon S; Lacroux C; Mathey J; Lamourette P; Relaño A; Torres JM; Créminon C; Grassi J
J Gen Virol; 2010 Jun; 91(Pt 6):1635-45. PubMed ID: 20107012
[TBL] [Abstract][Full Text] [Related]
16. Prions and peripheral nerves: a deadly rendezvous.
Heikenwalder M; Julius C; Aguzzi A
J Neurosci Res; 2007 Sep; 85(12):2714-25. PubMed ID: 17393538
[TBL] [Abstract][Full Text] [Related]
17. Cell culture models of transmissible spongiform encephalopathies.
Béranger F; Mangé A; Solassol J; Lehmann S
Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
19. [Amyloidgenesis in prion disease].
Tsuboi Y
Brain Nerve; 2014 Jul; 66(7):849-55. PubMed ID: 24998829
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches targeting the prion receptor LRP/LR.
Zuber C; Ludewigs H; Weiss S
Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
